MRNA's mRNA-1010 flu vaccine outperforms GSK's shot by 26.6% in a large phase III trial of adults 50 and older.

Seasonal flu-related hospitalizations and outpatient visits reached a 15-year high during the 2024-25 season, according to ...

Moderna has reported positive phase 3 results for its seasonal flu vaccine, mRNA-1010, which outperformed a standard-dose ...

A confirmed H1N1 outbreak has hit Anum Senior High School, with all nine samples from the school testing positive.

Moderna today reported promising relative vaccine efficacy (rVE) findings from a phase 3 trial of its seasonal mRNA flu ...

Presented by Vaccinate Your Family{beacon} Health Care Health Care   The Big Story Senate set to vote on amendment rolling ...

Amid promising signs, officials urged caution, noting that the outbreaks vary by clade, response measures, and social ...

From cheeky to punny, these hilarious "what's the difference between" jokes are guaranteed to bring the laughs ...